KRN7000 applied to myeloma research

Tumor cells loaded with α-galactosylceramide promote therapeutic NKT-dependent anti-tumor immunity in multiple myeloma

A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma

 

 

 

 

 

 

 

 

 

 

 

New 7DW8-5 glycolipid

7DW8-5

Now available 7DW8-5 glycolipid derivative of Alpha-GalCer for human and mice iNKT immunoresearch

 

Meet Funakoshi Company
at the following meetings:



ASCB
Philadelphia, PA
December 2-6, 2017